JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frey, C.
Right arrow Articles by Griffith, O. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frey, C.
Right arrow Articles by Griffith, O. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 269, Issue 42, 26083-26091, 10, 1994

L-thiocitrulline. A stereospecific, heme-binding inhibitor of nitric- oxide synthases

C Frey, K Narayanan, K McMillan, L Spack, SS Gross, BS Masters and OW Griffith
Department of Biochemistry, Medical College of Wisconsin, Milwaukee 53226.

Nitric-oxide synthase (NOS) catalyzes the oxidation of L-arginine to citrulline and nitric oxide (NO). The enzyme is inhibited by a variety of N omega-monosubstituted L-arginine analogs, and some of these compounds are useful in reversing pathologies associated with the overproduction of NO (e.g. the hypotension of septic shock). We report here that L-thiocitrulline (gamma-thioureido-L-norvaline) is a potent, stereospecific inhibitor of the constitutive brain and endothelial isoforms of NOS as well as the isoform induced in vascular smooth muscle cells by lipopolysaccharide and interferon-gamma. Steady state kinetic studies show L-thiocitrulline inhibition is competitive with L- arginine (Ki approximately 4-20% of KArgm), indicating that initial binding is as a substrate/product analog. In contrast to L-arginine and N omega-methyl-L-arginine, the prototypic NOS inhibitor, L- thiocitrulline binding elicits a "Type II" difference spectrum, indicating a high spin to low spin transition of the iron in the heme cofactor. This finding suggests that L-thiocitrulline is contributing the sixth ligand to heme iron, probably through the thioureido sulfur. Such interaction with heme iron neither stimulates nor inhibits the direct flavin-mediated cytochrome c reduction activity of the enzyme, but it does inhibit heme-dependent superoxide formation. In vivo, L- thiocitrulline is a potent pressor agent in both normal and endotoxemic rats, the latter finding suggesting utility in treating the hypotension of septic shock.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
B. R. Babu, C. Frey, and O. W. Griffith
L-Arginine Binding to Nitric-oxide Synthase. THE ROLE OF H-BONDS TO THE NONREACTIVE GUANIDINIUM NITROGENS
J. Biol. Chem., September 3, 1999; 274(36): 25218 - 25226.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. A. Gunnett, Y. Chu, D. D. Heistad, A. Loihl, and F. M. Faraci
Vascular effects of LPS in mice deficient in expression of the gene for inducible nitric oxide synthase
Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H416 - H421.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. R. Babu and O. W. Griffith
N5-(1-Imino-3-butenyl)-L-ornithine. A NEURONAL ISOFORM SELECTIVE MECHANISM-BASED INACTIVATOR OF NITRIC OXIDE SYNTHASE
J. Biol. Chem., April 10, 1998; 273(15): 8882 - 8889.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Garcia-Cardena, P. Martasek, B. S. S. Masters, P. M. Skidd, J. Couet, S. Li, M. P. Lisanti, and W. C. Sessa
Dissecting the Interaction between Nitric Oxide Synthase (NOS) and Caveolin. FUNCTIONAL SIGNIFICANCE OF THE NOS CAVEOLIN BINDING DOMAIN IN VIVO
J. Biol. Chem., October 10, 1997; 272(41): 25437 - 25440.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. Moncada, A. Higgs, and R. Furchgott
XIV. International Union of Pharmacology Nomenclature in Nitric Oxide Research
Pharmacol. Rev., June 1, 1997; 49(2): 137 - 142.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P.-F. Chen, A.-L. Tsai, V. Berka, and K. K. Wu
Mutation of Glu-361 in Human Endothelial Nitric-oxide Synthase Selectively Abolishes L-Arginine Binding without Perturbing the Behavior of Heme and Other Redox Centers
J. Biol. Chem., March 7, 1997; 272(10): 6114 - 6118.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Berka, P.-F. Chen, and A.-L. Tsai
Spatial Relationship between L-Arginine and Heme Binding Sites of Endothelial Nitric-oxide Synthase
J. Biol. Chem., December 27, 1996; 271(52): 33293 - 33300.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Gachhui, A. Presta, D. F. Bentley, H. M. Abu-Soud, R. McArthur, G. Brudvig, D. K. Ghosh, and D. J. Stuehr
Characterization of the Reductase Domain of Rat Neuronal Nitric Oxide Synthase Generated in the Methylotrophic Yeast Pichia pastoris. CALMODULIN RESPONSE IS COMPLETE WITHIN THE REDUCTASE DOMAIN ITSELF
J. Biol. Chem., August 23, 1996; 271(34): 20594 - 20602.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. C. Salerno, C. Frey, K. McMillan, R. F. Williams, B. S. S. Masters, and O. W. Griffith
Characterization by Electron Paramagnetic Resonance of the Interactions of L-Arginine and L-Thiocitrulline with the Heme Cofactor Region of Nitric Oxide Synthase
J. Biol. Chem., November 17, 1995; 270(46): 27423 - 27428.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. A. Pritchard Jr, L. Groszek, D. M. Smalley, W. C. Sessa, M. Wu, P. Villalon, M. S. Wolin, and M. B. Stemerman
Native Low-Density Lipoprotein Increases Endothelial Cell Nitric Oxide Synthase Generation of Superoxide Anion
Circ. Res., September 1, 1995; 77(3): 510 - 518.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Santolini, S. Adak, C. M. L. Curran, and D. J. Stuehr
A Kinetic Simulation Model That Describes Catalysis and Regulation in Nitric-oxide Synthase
J. Biol. Chem., January 5, 2001; 276(2): 1233 - 1243.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Kotsonis, L. G. Frohlich, C. S. Raman, H. Li, M. Berg, R. Gerwig, V. Groehn, Y. Kang, N. Al-Masoudi, S. Taghavi-Moghadam, et al.
Structural Basis for Pterin Antagonism in Nitric-oxide Synthase. DEVELOPMENT OF NOVEL 4-OXO-PTERIDINE ANTAGONISTS OF (6R)-5,6,7,8-TETRAHYDROBIOPTERIN
J. Biol. Chem., December 21, 2001; 276(52): 49133 - 49141.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1994 by the American Society for Biochemistry and Molecular Biology.